Ocular Hypertension

Showing NaN - NaN of 32

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Open Angle Glaucoma, Ocular Hypertension Trial in United States (Travoprost, Placebo Vehicle)

Completed
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Artesia, California
  • +9 more
Sep 14, 2021

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (PF-04217329 - Lowest Dose, PF-04217329 - Low Dose,

Completed
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • PF-04217329 - Lowest Dose
  • +8 more
  • Artesia, California
  • +22 more
Apr 6, 2021

Open Angle Glaucoma, Ocular Hypertension Trial in United States (Xalacom, Xalatan, Timolol)

Completed
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Birmingham, Alabama
  • +63 more
Feb 17, 2021

Open Angle Glaucoma, Ocular Hypertension Trial in Worldwide (1 drop of 0.375% SYL040012 (bamosiran), 1 drop of 0.750% SYL040012

Completed
  • Open Angle Glaucoma
  • Ocular Hypertension
  • 1 drop of 0.375% SYL040012 (bamosiran)
  • +4 more
  • Artesia, California
  • +20 more
Dec 11, 2020

Glaucoma, Ocular Hypertension Trial in United States (RKI983A, Latanoprost)

Completed
  • Glaucoma
  • Ocular Hypertension
  • Artesia, California
  • +28 more
Dec 11, 2020

Primary Open Angle Glaucoma, Ocular Hypertension, Pigmentary Glaucoma Trial in United States (PF-03187207 and Latanoprost

Completed
  • Primary Open Angle Glaucoma
  • +3 more
  • PF-03187207 and Latanoprost Vehicle
  • Latanoprost 0.005% and PF-03187207 Vehicle
  • Artesia, California
  • +18 more
Sep 10, 2020

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost, Timolol 0.5%, Placebo Ocular Insert)

Completed
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Fayetteville, Arkansas
  • +9 more
May 18, 2020

Glaucoma, Open-angle, Ocular Hypertension Trial in United States (0.01% RO7058584, 0.1% RO7058584, 1% RO7058584)

Completed
  • Glaucoma, Open-angle
  • Ocular Hypertension
  • 0.01% RO7058584
  • +4 more
  • Chandler, Arizona
  • +7 more
Mar 27, 2020

Open-Angle Glaucoma, Ocular Hypertension Trial in Worldwide (bimatoprost 20 µg generation 2, bimatoprost 15 µg generation 2,

Completed
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • bimatoprost 20 µg generation 2
  • +6 more
  • Artesia, California
  • +56 more
Mar 27, 2020

Open Angle Glaucoma, Ocular Hypertension Trial in United States (PG324 Ophthalmic Solution 0.01%, PG324 Ophthalmic Solution

Completed
  • Open Angle Glaucoma
  • Ocular Hypertension
  • PG324 Ophthalmic Solution 0.01%
  • +3 more
  • Artesia, California
  • +22 more
May 14, 2019

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost)

Completed
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Fayetteville, Arkansas
  • +8 more
Mar 26, 2019

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost)

Completed
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Artesia, California
  • +9 more
Feb 1, 2019

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost, Timolol 0.5%, Placebo Eye Drops)

Completed
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Artesia, California
  • +9 more
Mar 22, 2018

Open-angle Glaucoma, Ocular Hypertension Trial in United States (DE-117 Low Dose ophthalmic solution, DE-117 Low/Middle Dose

Completed
  • Open-angle Glaucoma
  • Ocular Hypertension
  • DE-117 Low Dose ophthalmic solution
  • +5 more
  • Chandler, Arizona
  • +13 more
Apr 16, 2018

Ocular Hypertension, Open Angle Glaucoma Trial in United States (AR-13324 Ophthalmic Solution 0.01%, AR-13324 Ophthalmic

Completed
  • Ocular Hypertension
  • Open Angle Glaucoma
  • AR-13324 Ophthalmic Solution 0.01%
  • +2 more
  • Artesia, California
  • +21 more
Mar 19, 2018

Glaucoma, Ocular Hypertension Trial in Artesia, El Paso (Bimatoprost 0.01%, Bimatoprost 0.03%)

Completed
  • Glaucoma
  • Ocular Hypertension
  • Bimatoprost 0.01%
  • Bimatoprost 0.03%
  • Artesia, California
  • +1 more
Apr 21, 2015

Glaucoma, Open-Angle, Ocular Hypertension Trial in United States (High Dose Device, Low Dose Device, Placebo Device)

Completed
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • High Dose Device
  • +2 more
  • Artesia, California
  • +3 more
Feb 18, 2015

Glaucoma, Ocular Hypertension, Eye Disease Trial in United States (AMA0076, Placebo)

Completed
  • Glaucoma
  • +2 more
  • Artesia, California
  • +8 more
Jan 16, 2015

Open Angle Glaucoma, Ocular Hypertension Trial in United States (PG286 Ophthalmic Solution 0.5%, AR-12286 Ophthalmic Solution

Completed
  • Open Angle Glaucoma
  • Ocular Hypertension
  • PG286 Ophthalmic Solution 0.5%
  • +2 more
  • Artesia, California
  • +20 more
Feb 17, 2014

Primary Open-angle Glaucoma, Ocular Hypertension Trial in United States (OPA-6566, Placebo, Latanoprost)

Completed
  • Primary Open-angle Glaucoma
  • Ocular Hypertension
  • Artesia, California
  • +8 more
Feb 7, 2014

Ocular Hypertension, Glaucoma Trial in Artesia (AGN-210669 ophthalmic solution, 0.075%, AGN-210669 ophthalmic solution, 0.05%,

Completed
  • Ocular Hypertension
  • Glaucoma
  • AGN-210669 ophthalmic solution, 0.075%
  • +4 more
  • Artesia, California
    (unnamed)
Aug 13, 2013

Glaucoma, Ocular Hypertension Trial in United States (Latanoprost-PPDS)

Completed
  • Glaucoma
  • Ocular Hypertension
  • Artesia, California
  • +7 more
Sep 16, 2013

Glaucoma, Ocular Hypertension, Eye Disease Trial in United States (AMA0076, Placebo)

Completed
  • Glaucoma
  • +2 more
  • Artesia, California
  • +5 more
Jul 16, 2013

Glaucoma, Ocular Hypertension Trial in Worldwide (bimatoprost /timolol formulation A fixed combination ophthalmic solution,

Completed
  • Glaucoma
  • Ocular Hypertension
  • bimatoprost /timolol formulation A fixed combination ophthalmic solution
  • bimatoprost/timolol fixed combination ophthalmic solution
  • Artesia, California
  • +8 more
Mar 22, 2013

Primary Open Angle Glaucoma, Ocular Hypertension Trial in United States (Stage 1 - ATS907 - Dose 1, Stage 1 - ATS907 - Dose 2,

Unknown status
  • Primary Open Angle Glaucoma
  • Ocular Hypertension
  • Stage 1 - ATS907 - Dose 1
  • +7 more
  • Artesia, California
  • +4 more
Oct 30, 2012